An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

Trial Profile

An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs GSK 3277511 (Primary)
  • Indications Respiratory tract disorders
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 06 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 03 Apr 2017 Planned End Date changed from 1 Mar 2017 to 3 Apr 2017.
    • 03 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 3 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top